Russell Investments Group, Ltd.
Position in TAK — Takeda Pharmaceutical Co Ltd
CIK 1692234
Seattle, WA
Position in TAK
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$2,399,228
+$840,509 QoQ
Shares Held
129,548
+29.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 94.22993793806157.ToString("F0")%
Shared 0.ToString("F0")%
None 5.770062061938432.ToString("F0")%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Russell Investments Group, Ltd. holds $291,116,040 across 50 Drug Manufacturers - Specialty & Generic names. TAK ranks #18 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
578,753 | $68,414,382 | |
| 2 | VTRS |
Viatris Inc
|
3,347,591 | $45,225,949 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
67,551 | $40,056,384 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
219,755 | $28,950,515 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
645,037 | $15,435,730 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
393,588 | $11,854,866 | |
| 7 | PAHC |
Phibro Animal Health Corp
|
193,436 | $10,698,942 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
138,941 | $10,684,560 |
All Filings in TAK
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,399,228 | 129,548 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $1,558,719 | 99,982 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,394,694 | 95,266 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,284,123 | 83,061 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $958,564 | 64,463 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $600,089 | 45,324 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $433,610 | 30,493 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $225,893 | 17,457 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $148,289 | 10,676 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $92,227 | 6,463 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $116,365 | 7,522 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $126,434 | 8,048 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $115,920 | 7,034 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $1,654,567 | 106,062 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $1,375,624 | 106,062 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $5,902,065 | 420,375 | Shares | Defined | 2022-07-29 | |
| 2022-03-31 | $5,284,266 | 369,013 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $5,192,593 | 380,968 | Shares | Defined | 2022-01-21 | |
| 2021-09-30 | $6,117,979 | 373,503 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $3,671,498 | 218,152 | Shares | Defined | 2021-08-04 | |
| 2020-06-30 | $289,103 | 16,124 | Shares | Defined | 2020-08-05 | |
| No filing history on record for this holder in this stock. | ||||||